BioCorRx Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2008
Net Income	-3.77	-4.37	-5.8	-4.01	-7.71	-6.51	-29.71	-5.9	-4.67	-3.13	Upgrade
Depreciation & Amortization	0.2	0.14	0.17	0.17	0.1	0.01	0.03	0.03	0.13	0.14	Upgrade
Share-Based Compensation	0.28	0.35	0.21	0.36	1.97	2.81	0.83	0.58	0.8	1.99	Upgrade
Other Operating Activities	1.44	1.83	1.89	1.34	2.71	1.87	26.3	3.3	3.79	1.17	Upgrade
Operating Cash Flow	-1.85	-2.04	-3.54	-2.15	-2.94	-1.83	-2.54	-1.99	0.05	0.17	Upgrade
Operating Cash Flow Growth	-	-	-	-	-	-	-	-	-71.46%	62.06%	Upgrade
Capital Expenditures	0	0	-0.05	-0.01	-0.12	-0.06	-0	-0.33	0	-0	Upgrade
Acquisitions	0	0	0	0	0	0	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-0.01	-	-0.03	Upgrade
Investing Cash Flow	0	0	-0.05	-0.01	-0.12	-0.06	-0	-0.34	0	-0.03	Upgrade
Common Stock Issued	0.92	1.25	2.25	0	6.1	1.4	0.94	0.1	0	172.5	Upgrade
Share Repurchases	0	0	0	0	0	0.23	0	0	1,132	0	Upgrade
Other Financing Activities	0.93	0.77	0.83	0.11	-0.68	0.98	1.47	2.1	1,132	-172.69	Upgrade
Financing Cash Flow	1.85	2.02	3.08	0.11	5.43	2.15	2.41	2.2	0.12	-0.19	Upgrade
Net Cash Flow	-0	-0.02	-0.51	-2.05	2.37	0.27	-0.13	-0.13	0.17	-0.06	Upgrade
Free Cash Flow	-1.85	-2.04	-3.59	-2.16	-3.06	-1.88	-2.54	-2.32	0.05	0.17	Upgrade
Free Cash Flow Growth	-	-	-	-	-	-	-	-	-71.37%	72.72%	Upgrade
Free Cash Flow Margin	-2078.60%	-954.81%	-7432.17%	-1762.42%	-1273.51%	-499.55%	-386.96%	-329.93%	5.18%	14.28%	Upgrade
Free Cash Flow Per Share	-0.22	-0.28	-0.55	-0.40	-0.87	-0.75	-0.01	-0.01	0.03	0.12	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.